Health & Well-Being

A group of children and an instructor sharing lunch.

Study: USDA’s Child and Adult Care Food Program Underused By Connecticut Child Care Centers

Low program awareness and burdensome paperwork cited as common reasons for lack of participation, which costs the state millions in foregone federal fund

Fentanyl is driving the surge in deadly overdoses both in Connecticut and nationwide.

Connecticut Urges Other States to Adapt Rapid Opioid Overdose Surveillance

As deadly overdoses spike, the ability to respond quickly becomes ever more urgent

The UConn Health Pulse Podcast logo.

Elite Expertise in Brain and Spine Disorders

Two physicians from the Brain and Spine Institute describe UConn Health's collaborative approach to treating those suffering from brain tumors, strokes, and other disorders of the brain and spine.

Companies are Pushing Sweetened Drinks to Children through Ads and Misleading Labels – and Families are Buying

There are dozens of options for children’s drinks in most supermarkets. Choosing the healthy options is difficult

UConn Health School of Medicine researchers Ming Xu, Binsheng Wang, and Lichao Wang.

UConn Researchers: Deleting Dysfunctional Cells Alleviates Diabetes

A discovery that could lead to game-changing treatments for metabolic diseases

Since the early 2000s, more clinical trials have been taking place overseas, where FDA oversight is lax.

The FDA’s Lax Oversight of Research in Developing Countries Can Do Harm to Vulnerable Participants

No on-site inspections, fraudulent data, and patients who didn't know they were participating in a clinical trial

A portrait of a student

Behind the Degree: DNP Student Plans to Use Her Advanced Education to Empower Her Patients and Other Nurses

Savitha Chandramohan is earning her Doctor of Nursing Practice degree so she can support development among her fellow nurses and reduce patients' costly hospital visits

From left, Drs. Xiaofang Wang and Ren-He Xu of ImStem Biotechnology, a UConn spin out developing novel therapies using stem cells, that was recently issued a patent for human embryonic stem cell derived mesenchymal stem cells and the method of producing the stem cells. (Tina Encarnacion/UConn Health File Photo)

TIP Company ImStem Biotechnology Doses First MS Patient in Clinical Trial

UConn TIP company ImSTEM Biotechnology is conducting a clinical trial to test their experimental human embryonic stem cell-derived mesenchymal stem cell therapy for the treatment of multiple sclerosis.

10 Ways to Beat the Holiday Blues (Starting Now)

Feeling stressed already? You're not alone

masked teens looking at their phones

Q&A: The Challenges of Pandemic-Era Readjustment for Children and Adolescents

Dr. Asima Zehgeer of UConn Health’s Child and Adolescent Psychiatry Outpatient Clinic discusses challenges faced by children and teens in the wake of COVID-19